Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative nicorandil for myocardial injury prevention after open heart surgery
IRCT20170620034666N6Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nicorandil in coronary arteriosclerosis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Troponin level, Occurrence of new arrhythmia and 2 more. Started Jun 2023; status: completed.
02
Drugs
nicorandil
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20170620034666N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170620034666N6.